go back

Idecabtagene Vicleucel (Abecma), up to 460 Million Cells

Tennessee rates for HCPCS C9081

Idecabtagene vicleucel, up to 460 million autologous anti-BCMA CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

How much rates vary

Facilitymedian $436,516 · 10th to 90th $436,516 to $436,516Professionalmedian $630,957 · 10th to 90th $630,957 to $630,957
$500Kfacility $436,516professional $630,957

Distribution of negotiated rates across all payers (price axis is log-scale). Each curve is scaled to its own total: facility and professional rates are different services, shown together to compare where they cluster. Small sample; interpret with caution. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
Lucent Health
Setting
Facility
Modifier
Global
Typical Low
$436,515.83
Median
$436,515.83
Typical High
$436,515.83
Lucent Health
Setting
Professional
Modifier
Global
Typical Low
$630,957.34
Median
$630,957.34
Typical High
$630,957.34